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Abstract
Elucidating the causes of congenital heart defects is made difficult by the complex morpho-
genesis of the mammalian heart, which takes place early in development, involves contribu-
tions from multiple germ layers, and is controlled by many genes. Here, we use a
conditional/invertible genetic strategy to identify the cell lineage(s) responsible for the devel-
opment of heart defects in a Nipbl-deficient mouse model of Cornelia de Lange Syndrome,
in which global yet subtle transcriptional dysregulation leads to development of atrial septal
defects (ASDs) at high frequency. Using an approach that allows for recombinase-mediated
creation or rescue of Nipbl deficiency in different lineages, we uncover complex interactions
between the cardiac mesoderm, endoderm, and the rest of the embryo, whereby the risk
conferred by genetic abnormality in any one lineage is modified, in a surprisingly non-addi-
tive way, by the status of others. We argue that these results are best understood in the con-
text of a model in which the risk of heart defects is associated with the adequacy of early
progenitor cell populations relative to the sizes of the structures they must eventually form.
Author Summary
Congenital heart defects, the most common birth defect, are thought mainly to arise
through interactions among multiple genes. We studied atrial septal defects (a common
type of heart defect) in a mouse model of Cornelia de Lange Syndrome, in which loss of
one copy of the Nipbl gene produces frequent developmental abnormalities. By causing
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subtle dysregulation of the expression of many hundreds of genes, Nipbl haploinsuffi-
ciency serves as a model for the polygenic origins of common birth defects. We used an
improved genetic technology to separately create or rescue deficiency for Nipbl within the
major cardiogenic tissue lineages (lineages that contribute to or control the morphogenesis
of the developing heart). Unexpectedly, we found that risk for developing atrial septal
defects could not be mapped to any single one of these cardiogenic lineages, but rather was
determined by non-additive interactions between these lineages and the rest of the body.
Intriguingly, being Nipbl-deficient in the rest of the body reduced the risk conferred by
being Nipbl-deficient in either of two distinct cardiogenic lineages. We hypothesize that
this effect is driven by developmental coupling between body size and heart size, with
defects arising when progenitor cells cannot be provided fast enough to meet the require-
ments imposed on the heart by other growing tissues. To our knowledge, this is the first
genetic demonstration that major risk factors for heart defects are likely to lie outside of
the heart itself.
Introduction
Congenital heart defects (CHDs) are the most common of human birth defects, and a leading
cause of perinatal morbidity and mortality [1]. The genetics of CHDs are complex, with only a
fraction being associated with chromosomal abnormalities or Mendelian developmental syn-
dromes [2–4]. As with most human birth defects, the majority of CHDs are non-syndromic
(isolated), and appear to be multifactorial and most likely polygenic [5–8].
Cornelia de Lange Syndrome (CdLS) is a multisystem birth defects disorder characterized
by craniofacial abnormalities, developmental delay in growth and maturation, neurological
deficits and intellectual disability, limb abnormalities (particularly of the arms and hands), as
well as defects in the visual, auditory, gastrointestinal, genitourinary, and cardiopulmonary sys-
tems [9–13]. CHDs are seen in about 30% of individuals with CdLS [14,15], with structural
defects of the ventricular septum (VSD) and atrial septum (ASD) being among the most
common.
The genetic cause of CdLS is, in most cases, haploinsufficiency for NIPBL (Nipped-B-homo-
logue), which encodes a ubiquitous protein that regulates the loading of cohesin onto chromo-
somes [16,17]. Cohesin, a multiprotein complex originally identified by its role in sister
chromatid cohesion, is now understood to play critical roles in the regulation of gene expres-
sion [18–20]. In support of this view, both CdLS patient cell lines and animal models of Nipbl
haploinsufficiency display small but significant changes in the expression of up to 1,000 or
more genes, in essentially every tissue [21–24]. Studies in mouse and zebrafish models suggest
that these gene expression changes—most too small to have phenotypic consequences individ-
ually—collectively cause the structural and functional defects observed in CdLS [23,25–27].
CdLS and related “cohesinopathies” [26] thus exemplify an emerging class of genetic disorders
—recently termed “transcriptomopathies” [27]—in which additive or synergistic effects of
quantitative variation in the levels of multiple gene products lie at the root of developmental
abnormalities. Such disorders provide a unique window into the kinds of multifactorial interac-
tions that likely underlie polygenic traits, including the majority of complex developmental
disease.
Among features of CdLS that are phenocopied in Nipbl-deficient animal models are CHDs
[22,23]. In particular, mouse models display a high frequency of ASD, which are both common
in CdLS and among the most common CHDs in non-syndromic settings [28,29]. Elucidating
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the processes that lead to CHDs in such mouse models could potentially provide valuable
insight into the multifactorial causation of birth defects. Yet the fact that gene expression is
globally affected in such animals also makes it difficult to know a priori in which cell types, or
at what developmental stages, to look for such processes. For heart defects, this is an especially
challenging issue, as development of the heart involves communication and interaction among
many cell types, in multiple tissues, across many stages of development [30–32].
Here, we address this problem by exploiting a new allelic series (NipblFLEX), in which cells, and
mice, can be toggled between wildtype and mutant conformations ofNipbl using Flip-Excision
(FLEX) technology [33]. We use this strategy both to create and rescueNipbl-deficiency in multi-
ple lineages during early heart development, including the cardiogenic mesoderm, endoderm, and
neural crest. Interestingly, the data do not support the assignment of CHD risk to a single cardiac
lineage, but rather suggest that the cardiogenic mesoderm, the endoderm, and other lineages all
participate, interacting in surprisingly non-additive, and even antagonistic, ways. We relate these
findings to morphological and gene expression changes that occur in earlyNipbl-deficient hearts,
and propose a model in which defects arise when the ability to generate cardiac tissue during very
early stages fails to keep up with the demands imposed by final heart size.
Results
Nipbl-Deficient Mice Display Heart Abnormalities throughout Embryonic
Development
In a previous study of a CdLS mouse model of Nipbl haploinsufficiency (Nipbl+/- mice), we
reported that about half of Nipbl+/- mice display defects in closure of the atrial septum (ASD)
between gestational days 15.5 and 17.5 (E15.5–E17.5) [22]. Because many of the nearly 100
genes that have been linked to the production of cardiac septal defects [34,35] influence heart
development through actions at early embryonic stages, long before cardiac septa form, we also
examined heart development in Nipbl+/- mice at successively earlier developmental stages to
determine whether earlier structural abnormalities could be found. Interestingly, even though
E17.5 Nipbl+/- mice do not usually display defects of the ventricular septum, we found evidence
for earlier abnormalities in ventricular septation. In particular, at E13.5, 77% of Nipbl+/- hearts
showed incomplete fusion or complete lack of contact of the developing ventricular septum
with the cardiac cushion, compared to 14% of wildtype hearts (Fig 1A).
Studies of Nipbl-deficient tissues and cells from Drosophila, mouse, zebrafish, and man all
indicate that the means by which Nipbl-deficiency causes birth defects is by subtly mis-regulat-
ing the expression of large numbers of genes [21–25]. Accordingly, we screened Nipbl+/- hearts
for abnormalities in the expression of genes known to be involved in cardiac septation. Using
quantitative reverse transcription PCR (qRT-PCR) as a rapid screen, we assessed expression of
29 such genes (S1 Table) from E10–10.5, when all four heart chambers have formed and septa-
tion has just begun; through E13.5, when ventricular septation is mostly complete [30].
Three genes (Hand1, Pitx2c, and cMyc) showed consistent changes in Nipbl+/- hearts (Fig
1B and S1 Fig). Levels of Hand1 and Pitx2 were increased (by up to 40%), while cMyc was
reduced by ~25% at E10. No statistically significant changes were detected for other tested
genes (except Nipbl itself which, as expected, was reduced in Nipbl+/- hearts [by ~50%; S1 Fig]).
One example of an unaffected gene (Mef2C, which plays a critical early role in vertebrate car-
diovascular development [36]) is shown in Fig 1B.
These relatively small alterations of gene expression are typical of transcriptional effects in
Nipbl-deficient animal models and CdLS cell lines [21,22,24,25]. In the case of cMyc, the
change is likely a direct effect, as cMyc down-regulation is a hallmark of Nipbl-deficiency in
almost every cell type and organism examined to date [21–24,37].
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Fig 1. Nipbl-deficient mice show abnormalities throughout heart development. A. Hematoxylin and Eosin Y
(H&E)-stained sectioned hearts illustrating delay in fusion of ventricular septum (VS) with cardiac cushion (CC) in
Nipbl+/-mice at E13.5. The majority of wildtype hearts display a fully-developed VS fused with the CC (left panels); 1/7
(14%) display a mild phenotype (contact between the CC and VS, but no fusion). 77% (10/13) of Nipbl+/- hearts show a
defect in VS fusion: 38% (5/13) have a complete lack of contact between VS and CC (right panels, green arrowhead);
38% (5/13) have a milder phenotype (contact between the CC and VS, but no fusion). Frequencies of each defect are
plotted in histogram. p = 0.0166, Fisher’s Exact test (Nipbl+/-, 10/13 versus wildtype, 1/7). a, atrium; lv, left ventricle; rv,
right ventricle; vs, ventricular septum. Size bar = 400 μm. B. Quantitative reverse transcription PCR (qRT-PCR) was
performed on hearts at different stages between E10 and E13.5. Relative expression of Hand1, Pitx2, and cMyc, but not
Mef2c, differed significantly inNipbl+/- versus wildtype hearts at indicated stages. Histogram shows mean ± standard
error of the mean (SEM) of relative gene expression. *p < 0.05, ** p < 0.01, Student’s t test (S1 Data). C. In situ
hybridization (ISH) for Hand1 at E10.5 showing similar pattern of expression betweenNipbl+/- and wildtype hearts. A
discrepancy in the size of the developing right ventricle of Nipbl+/- hearts is observable (black asterisk). Size
bar = 400 μm. D. Left and right ventricle diameters were measured from whole mount E10.5 heart images using
Axiovision software (Zeiss). Histograms plot means (± SEM) for right and left ventricle diameters of Nipbl+/- hearts
(n = 5) and stage-matched wildtype littermate controls (n = 7). * p < 0.05, Student’s t test. E. OPT images showing
sections and 3-D reconstructions of E10.5 hearts, illustrating that right ventricles are smaller in E10.5Nipbl+/- hearts
(white asterisk). Size bar = 400 μm. F. ISH at cardiac crescent stage (E7.5) shows a reduction in Nkx2-5 expression in
the cardiac crescent (CC) ofNipbl+/-mice (n = 2) compared to wildtype littermates (n = 3). ML, midline; HF, headfold.
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Hand1 and Pitx2 are genes that both play a role in left-right asymmetry. Pitx2 encodes a
homeobox transcription factor critical for left-right patterning of the entire body, and is prefer-
entially expressed in left-sided cardiac structures from as early as cardiac crescent stage [38],
and Pitx2mutations have been associated with cardiac defects, including septal defects [39–
42].Hand1 encodes a basic helix-loop-helix transcription factor that is preferentially expressed
in the left ventricle, and is important for its development [43–45].
Because both Pitx2 and Hand1 are associated with left heart structures, we wondered
whether their elevated levels in E10–10.5 Nipbl+/- hearts was due to a change in gene regulation,
or a change in the proportions of left-sided versus right-sided tissue. Close inspection of hearts
in which Hand1 was visualized by in situ hybridization (ISH; Fig 1C and 1D), as well as hearts
imaged by optical projection tomography (OPT; Fig 1E), supports the latter explanation. As
shown in Fig 1C, E10.5 Nipbl+/- hearts display a relatively normal pattern and intensity of
Hand1 expression (by ISH), but the right ventricle is abnormally small. This could be demon-
strated consistently across embryos (Fig 1D) and was also evident in optical cross-sections
through the heart (Fig 1E).
These results suggest that the origins of heart defects in Nipbl+/- mice lie earlier in develop-
ment, in events that determine the relative amounts of left and right tissue that contribute to
the heart. Among the most important genes upstream ofHand1 and Pitx2 is Nkx2-5 [46,47],
which regulates many heart development genes [43]. Nkx2-5 can be detected as early as E7.5 in
the cardiac crescent, the collection of cardiogenic mesodermal cells that later coalesce to form
the early heart tube [48]. We used ISH to examine Nkx2-5 expression at this stage (Fig 1F) and
found that while the morphology of the cardiac crescent appears normal in Nipbl +/- embryos,
the strength of hybridization signal for Nkx2-5 is noticeably lower than in wildtype littermates,
suggesting that either fewer cardiac progenitor cells are present, or these cells express Nkx2-5 at
a reduced level.
The earliest-known marker of cardiogenic mesoderm isMesp1, which acts upstream of
Nkx2-5 to drive initial specification of cardiac stem/progenitor cells [49–52].Mesp1 first
appears in the lateral plate mesoderm at the primitive streak stage, about E6.5. By ISH, we
observe a dramatic reduction inMesp1 in Nipbl+/- embryos at E6.5 (Fig 1G) which we suspect,
given the critical role ofMesp1 in cardiac development, is probably due to delayed onset of
Mesp1 expression, rather than a loss of the capacity to expressMesp1.
Overall, these data indicate that heart development is abnormal in Nipbl+/- embryos from
the earliest developmental times at which cardiogenic tissue is formed. These abnormalities are
reflected in reduced expression of key transcription factors at appropriate stages, and delayed
growth and development of right-ventricular structures and the interventricular septum.
Generation of a Conditional/Invertible Nipbl Allelic Series Permits
Tissue-Specific Creation and Rescue of Nipbl Expression Deficiency
Elucidating the mechanisms that underlie structural defects in Nipbl-deficient hearts is compli-
cated by the fact that Nipbl is a ubiquitously expressed gene, and Nipbl-deficiency undoubtedly
affects gene expression in every tissue of the embryo. Even given the data in Fig 1, which show
changes in the expression of cardiac developmental genes at multiple stages of heart develop-
ment, it is possible that the actual cause of ASDs lies elsewhere, especially since morphogenesis
of the heart involves coordinated interaction among multiple cell types and tissue lineages. For
Scale bar: 200 μm. G. ISH at primitive streak stage (E6.5) shows a drastic reduction inMesp1 expression inNipbl+/-
embryos (n = 5, black arrowhead) compared to wildtype littermates (n = 5). A, anterior; P, posterior. Scale bar: 200 μm.
doi:10.1371/journal.pbio.2000197.g001
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example, the proper specification and patterning of cardiac mesoderm requires interaction
with endodermal cells that provide a substrate along which cardiac progenitors migrate to
form the cardiac crescent [31]. Indeed, in zebrafish, gene expression abnormalities in the endo-
derm appear to be the direct cause of some—but not all—cardiac abnormalities that accom-
pany Nipbl deficiency [23]. Another lineage that contributes substantially to the heart is the
neural crest, which although ectodermal in origin, contributes to the cardiac cushion and out-
flow tract and has been implicated in the etiology of septal defects [34].
To make it possible to investigate the roles of different cell lineages in the development of
heart defects in Nipbl-deficient mice, we developed a Nipbl allelic series based on embryonic
stem (ES) cells bearing a “conditional-invertible” (FLEX, or Flip-Excision [33,53,54]) gene trap
in the Nipbl locus. We tested several Nipbl-gene-trapped ES cells that are available through
public repositories, and ultimately selected, verified, and generated mice using ES cells bearing
the NipblGt(EUCE313f02)Hmgu allele (MGI: 4374347, hereafter known as NipblFLEX), which is
depicted in Fig 2A (see also S2 Fig). The gene-trap vector in these cells is inserted into intron 1
(14.5 kb downstream of exon 1) of the Nipbl gene, the same intron in which the gene-trap vec-
tor was inserted in the ES cells we used previously to generate Nipbl+/- mice [22].
This vector introduces a FLEX cassette, which contains a β-geo reporter that reports on suc-
cessful trapping, as well as flanking heterotypic recombinase target sites for both Cre and Flp
recombinases [33,53,54], oriented so that exposure to either of these recombinases should lead
to irreversible inversion of the trapping vector (due to excision of the cognate binding sites),
loss of trapping, and loss of β-geo expression. Subsequent exposure to the other recombinase
can then be used to induce a second round of irreversible inversion, restoring both trapping
and β-geo expression. The different configurations of alleles in the NipblFLEX series, as well as
the phenotypes of the different mouse lines obtained by successive rounds of recombination,
are detailed in Fig 2B–2E, S2 and S3 Figs.
Fig 2B illustrates salient features of NipblFLEX/+mice, which were generated directly from
chimeras produced using ES cells carrying the NipblFLEX allele. NipblFLEX/+ mice are, in accor-
dance with predictions for the first (trapped) allele in the series, haploinsufficient for Nipbl and
phenotypically similar to Nipbl+/- mice by every measure tested: small body size, ubiquitous
expression of the β-geo reporter, and reduced expression of Nipbl (assessed by qRT-PCR) (Fig
2B). In addition, NipblFLEX/+ mice have a low survival rate, with only about 4% of pups surviv-
ing to weaning (4 NipblFLEX/+ survivors versus 104 wildtype littermate survivors across 17 lit-
ters; S3 Fig). As discussed in the next section, NipblFLEX/+ mice also faithfully replicate the
heart defects seen in Nipbl+/- mice.
When Nipbl FLEX/+ mice are crossed with transgenic Actin-FlpE (Fig 2C) or Nanog-Cremice
(Fig 2D), to produce the genotypes we designate as NipblFlox/+ and NipblFlrt/+, respectively, the
progeny are normal in phenotype: embryos no longer express β-geo (note lack of X-gal stain-
ing), Nipbl transcript levels are restored to normal, and animals are indistinguishable from
wildtype littermates in terms of size, rates of survival, and weight (Fig 2C and 2D and S3 Fig).
Finally, when NipblFlox/+ mice are crossed with Nanog-Cremice to re-invert the gene-trap and
generate what we refer to as NipblFIN/+ mice, the NipblFIN/+ progeny are again Nipbl-deficient,
small in size, show ubiquitous β-geo expression, and survive poorly (Fig 2E legend). These
results demonstrate that mice from the NipblFLEX allelic series can be successfully “toggled”
between mutant and wildtype genotypes and phenotypes.
Nipbl FLEX/+ andNipbl+/-Mice Develop Similar Heart Defects
To confirm that Nipbl FLEX mice phenocopy Nipbl-deficient mice, we compared a large number
of hearts from NipblFLEX/+ and Nipbl+/- embryos (and their wildtype littermates) at E17.5. We
Multi-Lineage Interactions Confer Congenital Heart Defect Risk
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Fig 2. FLEX alleles allow successive toggling betweenmutant and wildtype genotypes and phenotypes.
A. Schematic of EUCE313f02 (NipblFLEX) allele from which the NipblFLEX/+mouse line and allelic series are
derived. The rsFlp-Rosa-βgeo cassette is inserted 14.5 kbp downstream of Nipbl Exon 1 on Chromosome 15.
B. In theNipblFLEX allele, the splice acceptor (SA) in the cassette traps Nipbl expression, resulting in termination
of Nipbl expression after exon 1 and expression of the β-geo reporter for the trapped null allele. Adult
Multi-Lineage Interactions Confer Congenital Heart Defect Risk
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used high-resolution (50 μm voxel diameter) magnetic resonance imaging (MRI) to scan rap-
idly through many specimens. Although this procedure detected heart defects with high accu-
racy (see Materials and Methods), we frequently confirmed defects by paraffin histology.
The results are shown in Fig 3. At E17.5, both NipblFLEX/+ and Nipbl+/- hearts display large
atrial-septal defects (ASDs) at a similar frequency, about 30% (Fig 3). This number is some-
what smaller than previously reported for Nipbl+/- mice (~50%), because a later time of assess-
ment and more stringent criteria were used here; by these criteria we observed no ASD in
wildtype littermates of NipblFLEX/+ and Nipbl+/- mice. We also examined a large number of
NipblFlox/+mice, and found only a single ASD among 48 hearts examined (i.e., 2%, Fig 3C). All
ASDs observed in Nipbl-deficient mice were of the ostium secundum type, similar to what is
observed in individuals with CdLS, when ASD is seen as an isolated cardiac defect [15]. Ven-
tricular septal defects were not observed in this analysis, nor were arterial stenoses or obvious
abnormalities of ventricular wall thickness (S4 Fig). We did note that the hearts of Nipbl-defi-
cient mice, whether NipblFLEX/+ or Nipbl+/-, are noticeably smaller than those of wildtype litter-
mates—to about the same degree that Nipbl-deficient embryos themselves are smaller than
wildtypes.
Characterization of Cre Lines for Tissue-Specific Manipulation of Nipbl
Deficiency
In principle, mice bearing NipblFLEX and NipblFlox alleles (Fig 2B and 2C) can be used to deter-
mine in which cells or tissues Nipbl-deficiency is either necessary or sufficient to cause the
heart defects that arise in globally Nipbl-deficient embryos. We selected six different Cre-
NipblFLEX/+mice are smaller than wildtype littermates: Image is of 4-wk-old male littermates. Scatter plot shows
weights of 12-wk-oldNipblFLEX/+mice (red, n = 3: 1 female, 2 males) and wildtype littermates (black, n = 8: 4
females, 4 males) from 3 litters. Ubiquitous expression of β-geowas detected by X-gal staining in E10.5
NipblFLEX/+ embryos. Histogram shows mean ± SEM of relative Nipbl expression, assessed by qRT-PCR, in
kidneys of E17.5NipblFLEX/+ (n = 8) and wildtype littermates (n = 6); asterisk: p < 0.05 by Student’s t test. C.
Mating NipblFLEX/+mice with mice carrying universal Flp recombinase inverts the SA-βgeo-pA at heterotypic
recognition targets (frt and F3 sites) and simultaneously excises cognate recognition sites, resulting in progeny
carrying the NipblFlox/+ allele. Inversion allows normal splicing between the endogenous Nipbl splice sites
(Exon 1 to Exon 2), thereby yielding a phenotypically wildtype allele.NipblFlox/+mice are similar to wildtype
littermates in size: Image is of 3-wk-old male littermates; scatter plot shows weights of 11-wk-oldNipblFlox/+
mice (red, n = 18: 4 female; 14 male) compared to wildtype littermates (black, n = 19: 4 female; 15 male) from 5
litters. Expression of β-geo is not detected by X-gal staining in E10.5NipblFlox/+ embryos. Histogram shows
qRT-PCR analysis of relative Nipbl expression in brain tissue of E17.5 in NipblFlox/+ (n = 8) versus wildtype
littermates (n = 7), plotted as in B; p > 0.05, Student’s t test. D. Mating NipblFLEX/+mice with mice carrying a
universal Cre recombinase causes recombination of theNipblFLEX allele (at LoxP and lox5171 recognition
sites), resulting in progeny carrying theNipblFlrt allele.NipblFlrt/+mice are phenotypically wildtype: Image is of
male NipblFlrt/+ and wildtype littermates at 3 wk of age showing no apparent difference in body size. Scatter plot
shows weights of 12-wk-oldNipblFlrt/+mice (red, n = 19: 6 female; 13 male) and wildtype littermates (black,
n = 10: 3 female; 7 male) from 3 litters. Expression of β-geowas not detected by X-gal staining in E10.5
NipblFlrt/+ embryos. qRT-PCR results show relativeNipbl expression in kidneys of E17.5NipblFlrt/+ (n = 6)
compared to wildtype littermates (n = 6), plotted as in B; p > 0.05 by Student’s t test. E. Cre-mediated
recombination of mice carrying the NipblFlox allele, obtained by crossingNipblFlox/+mice with Nanog-Cre
hemizygous mice, results in re-inversion of the SA-βgeo-pA cassette and re-trapping ofNipbl expression.
Resulting progeny (NipblFIN/+ mice) are phenotypically mutant, and survive poorly, with only 13NipblFIN/+ mice
(4%) surviving to weaning age out of 315 total pups born (significantly less than the expected 25% survival,
p < 0.001 by Chi-square analysis). AdultNipblFIN/+mice are smaller than wildtype littermates: Image is of 6-wk
old males; scatter plot shows weights of 8-wk-old NipblFIN/+mice (red, n = 11: 4 females; 7 males) compared to
wildtype littermates (black, n = 7: 3 females; 4 males) from 16 litters. Ubiquitous expression of β-geo is detected
by X-gal staining. qRT-PCR results show reducedNipbl expression in brains of E17.5NipblFIN/+ (n = 7)
compared to wildtype littermates (n = 6), plotted as in B; asterisk: p < 0.05, Student’s t test. Scale bars = 1 mm
for all panels. Frt (purple triangles), F3 (green triangles), loxP (orange triangles) and lox5171 (yellow triangles);
SA, splice acceptor; β-geo, β-galactosidase/neomycin phosphotransferase fusion gene; pA, bovine growth
hormone polyadenylation sequence.
doi:10.1371/journal.pbio.2000197.g002
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Fig 3. Nipbl FLEX/+ andNipbl+/-mice develop heart defects at the same high frequency. A, B. Paraffin-sectioned hearts stained with H&E (A)
and MRI-scanned hearts (B) show large atrial septal defects (yellow arrowheads) in Nipbl+/- andNipblFLEX/+mice, but not in wildtype or NipblFlox/+
mice. Scans and histology were performed on fixed tissue from E17.5 embryos. Scale bar = 500 μm. la, left atrium; lv left ventricle; ra, right atrium;
rv right ventricle; S, septum. C. Summary table showing incidence of atrial septal defects (ASDs) and ventricular septal defects (VSDs) in hearts of
Nipbl+/-, NipblFLEX/+, NipblFlox/+mice and wildtype littermate embryos at E17.5. Asterisks: p < 0.01 by Chi-square analysis. Data were pooled from
analyses of multiple crosses (see S1 Data: Sample Numbers) and progeny are on various backgrounds depending on parental backgrounds:
Nipbl+/-, CD-1;NipblFLEX/+, mixed;NipblFlox/+, C57Bl6/J or mixed.
doi:10.1371/journal.pbio.2000197.g003
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expressing mouse lines to use in such experiments. Two of them—Nkx2-5-Cre [55] and cTnt-
Cre [56]—express Cre in the cardiac crescent and developing cardiomyocytes. Two others,
Sox17-A2-iCre [57] and FoxA2-2A-iCre [58] have been reported to express Cre primarily in
early endoderm, at a time when cardiac progenitors receive important developmental signals
from this tissue [31].Wnt1-Cre [59] was chosen because it expresses Cre in the neural crest
and its derivatives, including portions of developing heart and outflow tracts [34]. Finally,
Nanog-Cre served as a positive control, as it expresses Cre in all cells of the developing embryo
[60].
To verify the domains of Cre expression in these lines, we crossed them with Td-tomato-
EGFP reporter mice [61], which express a membrane-targeted tomato red fluorescent protein
that is replaced by a membrane-targeted enhanced green fluorescent protein (EGFP) when
Cre-mediated excision occurs. As shown in Fig 4A, Nanog-Cre embryos express EGFP in all
cells of the blastocyst inner cell mass, as expected. Nkx2-5-Cre and cTnt-Cre embryos express
EGFP primarily in heart at E9–10.5, with some EGFP apparent in the first branchial arch for
Nkx2-5-Cre. At E13.5, hearts ofWnt1-Cre embryos express EGFP in the inner lining of the
great arteries and cardiac cushion, consistent with the distribution of neural crest contributions
to the heart [62]. In Sox17-2A-iCre and FoxA2-2A-iCre embryos at E8–8.5, EGFP expression is
observed in endodermal derivatives (foregut and hindgut), with small numbers of EGFP+ cells
in developing heart. FoxA2-2A-iCre embryos also displayed some ectodermal (floorplate) and
mesodermal (somite) EGFP.
Because recombination of the NipblFlox allele reactivates expression of β-geo, we could also
use X-gal staining to document patterns of Nipbl inactivation produced by these Cre lines (Fig
4B–4F). These results confirm that Nanog-Cre drives ubiquitous recombination (Fig 4B), while
cTnt-Cre drives recombination specifically in the heart, and solely in myocardium (note spar-
ing of the cardiac cushion in Fig 4C). Sox17-2A-iCre drives recombination in endodermal
derivatives such as foregut and hindgut at E8.5, with additional staining in the heart that, by
E10.5, can be seen to correspond to endocardium and cardiac cushion (Fig 4D), a pattern com-
plementary to cTnt-Cre. Although FoxA2 is often regarded as an endodermal marker, the pat-
tern of recombination driven by FoxA2-2A-iCre is more complex (consistent with its broader
expression pattern compared to Sox17-2A-iCre in Fig 4A), and eventually comes to include
sub-portions of epi-, myo-, and endocardium, while mainly sparing the anterior heart, outflow
tracts and cardiac cushion (Fig 4E).Wnt1-Cre embryos show essentially no recombination in
the heart proper at E10.5, with X-gal staining appearing by E13.5 in a pattern confined to the
cardiac cushion and developing great arteries (Fig 4F).
These results document that these Cre lines can be used to manipulate Nipbl expression in
essentially all of the major tissues that contribute to, or influence the development of, the heart.
Furthermore, while some show overlapping patterns of recombination, cTnt-Cre and Sox17-
2A-iCre are essentially complementary to one another—the former acting within the cardio-
myocyte lineage, and the latter acting within endoderm plus non-cardiomyocyte mesodermal
derivatives within the heart: the endocardium, endocardially-derived cells of the cardiac cush-
ion, and vascular endothelium (these correspond to known domains of Sox17 expression [63]).
Indeed, high magnification views of Td-tomato-EGFP reporter expression at E15.5 show that
cTnt-Cre (Fig 4C’) recombines in the vast majority of heart cells, including cells of the atrial
septum, but spares endocardium, the cushion-derived atrioventricular valves, and scattered
EGFP-negative cells in the ventricular parenchyma (most likely endothelial cells lining small
blood vessels). In contrast, Sox17-2A-iCre spares the myocardium, but drives recombination in
endocardium, atrioventricular valves, and small blood vessels throughout the ventricles
(Fig 4D’).
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Fig 4. Domains of Cre expression in mice madeNipbl-deficient in different heart developmental lineages. A. Relevant patterns of Cre expression
from the six Cre lines used in this study (Nanog-Cre, Nkx2-5-Cre, cTnt-Cre, Sox17-2A-iCre, FoxA2-2A-iCre,Wnt1-Cre), assessed on the Td-Tomato-EGFP
reporter during early embryogenesis. Cre-mediated recombination is indicated by expression of EGFP. Note two embryos are shown in theNanog-Cre
panel; only the embryo on the right carries theNanog-Cre allele and exhibits EGFP expression in the inner cell mass (icm). B–F. X-gal staining was
performed to detect expression of β-geo inNipblFlox/+ embryos carrying one of the Cre transgenes. X-gal staining was assessed in whole embryos (at E8–
10.5, left panels), whole hearts (at E10.5, middle panels in B-E and at E13.5 in NipblFlox/+;Wnt1-cre hearts, right panel in F), and sectioned hearts (at E10.5,
right panels B-E). C’–E’. Confocal images of E15.5 hearts generated from crosses ofNipblFlox/+;Td-Tomato-EGFPmice with different Cre-expressing lines.
(C’) cTnt-Cre: EGFP in myocardium including atrial septum. (D’) Sox17-2A-iCre: EGFP in endocardium, and small blood vessels. (E’) FoxA2-2A-iCre:
EGFP in both endoderm (bronchi linings) and some mesoderm (muscle in ventricle); minimal EGFP expression in atrial septum (note that pattern is different
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Effects of Nipbl Deficiency in Single Developmental Lineages
We first crossed mice carrying Cre-expressing transgenes with NipblFlox/+ mice, to yield prog-
eny in which Nipbl deficiency is introduced into specific lineages, while the rest of the embryo
retains normal Nipbl expression (Fig 5). Nanog-Cre was used as a control to produce mice that
were Nipbl-deficient in all tissues. When NipblFlox/+;Nanog-Cre progeny were analyzed at
E17.5, 33% of hearts displayed heart defects, the vast majority of which were large ASDs (Fig
5A). These results are similar to those observed for E17.5 hearts from both Nipbl+/- and
NipblFLEX/+ mice (Fig 3).
Next, cTnt-Cre was used to create Nipbl deficiency specifically in cardiomyocytes (Fig 5B).
In this case, large ASDs were also found at a frequency of 30%, not significantly different from
that seen with Nipbl+/-, NipblFLEX/+, or NipblFlox/+;Nanog-Cre progeny (Figs 3C and 5A, S1
Data). This finding suggested that Nipbl deficiency in cardiomyocytes accounts for the high
incidence of heart defects seen in globally Nipbl-deficient animals.
However, subsequent experiments suggested otherwise. Use of either Sox17-2A-iCre
(expressed in endoderm and non-cardiomyocyte mesodermal derivatives) or FoxA2-2A-iCre
(expressed both in endodermal and multiple other derivatives) to create Nipbl deficiency also
resulted in a high incidence of ASD, about 26% in each case (Fig 5C and 5D). This is nearly as
high as, and not statistically significantly different from, the level caused by either global or car-
diomyocyte-specific Nipbl-deficiency (S1 Data).
Finally, we usedWnt1-Cre to investigate the role of neural crest. The neural crest not only
contributes cells to cardiac structures, such as outflow tracts and valves, migrating neural crest
cells interact in important ways with other cells that contribute to the heart [31,64]. Smith et al.
[65] have suggested that Nipbl deficiency in mice impairs the functioning of cranial neural
crest, and Schuster et al., [66], using zebrafish, recently proposed a neural crest origin for heart
defects in cohesinopathies. In our experiments, however, no heart defects were seen in
NipblFlox/+;Wnt1-Cre progeny (Fig 5E), indicating that Nipbl deficiency in the neural crest, at
least on its own, is not sufficient to produce heart defects.
Overall our results show that when cells derived from cardiogenic mesoderm, endoderm, or
subpopulations of both are made deficient in Nipbl, heart defects, primarily ASD, always
develop at a frequency of approximately 30%, the same incidence as observed in mice that are
globally Nipbl-deficient (Figs 3 and 5A, and S1 Data). This is a striking finding, since it suggests
that the effects of Nipbl-deficiency in different cardiac developmental lineages, even non-over-
lapping lineages, are not additive.
Restoration of Nipbl Expression to Either of Two Distinct Lineages
Rescues Heart Defects
In experiments complementary to those described above, we crossed NipblFLEX/+ mice with
Cre-expressing transgenic mice, to produce embryos that are globally Nipbl-deficient except
within those lineages in which Cre recombinase acts. We focused on three Cre-expressing
lines: Nanog-Cre, cTnt-Cre, and Sox17-2A-iCre.
As shown in Fig 6A, the hearts of NipblFLEX/+;Nanog-Cremice lacked ASDs, and were phe-
notypically indistinguishable from wildtype, as expected for a global rescue of Nipbl expression.
Interestingly, in NipblFLEX/+;cTnt-Cre hearts, the incidence of ASDs was also very low: of 19
from Sox17-2A-iCre). ao, aorta; av, atrioventricular valve; ba1, branchial arch; br, bronchi; cc, cardiac cushion; drg, dorsal root ganglion; en, endocardium;
ep, epicardium; fp, floor plate; fg, foregut; h, heart; hg, hindgut; icm, inner cell mass; la, left atria; lv, left ventricle; mb, midbrain; mc, myocardium; oft, outflow
tract; pa, pulmonary artery; ph, pharyngeal arches; ra, right atria; rv, right ventricle; som, somites; th, thymus; tr, trachea
doi:10.1371/journal.pbio.2000197.g004
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Fig 5. Creation ofNipbl deficiency in cardiac developmental lineages.NipblFlox/+mice were crossed with
mice hemizygous for each of five indicated Cre-expressing transgenes. MRI analysis of hearts was
performed at E17.5. A–D show that whether Nipbl was made deficient in all tissues (Nanog-Cre, A),
specifically in cardiomyocytes (cTnt-Cre, B), or primarily in endoderm-derived tissues (Sox17-2A-iCre, C) or
mixed cardiac lineages (FoxA2-2A-iCre, D), the incidence of CHDs (primarily ASDs) was approximately 30%.
(Chi-square analyses indicate that frequencies of heart defects observed in embryos with Nipbl deficiency in
experiments A–D do not differ significantly from each other [p > 0.4 for each pairwise comparison].) In
contrast, control hearts (a mix of wildtype,NipblFlox/+, andCre+ littermates for each specific cross; see S1
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hearts analyzed, only 1 displayed an ASD (~5%), which is significantly different from
NipblFLEX/+, and statistically indistinguishable from wildtype (S1 Data). Remarkably,
NipblFLEX/+;Sox17-2A-iCre hearts also displayed a very low incidence of ASDs (5%, Fig 6C and
6D) that was indistinguishable from wildtype (S1 Data). Chi-square analysis indicated that, for
all three types of NipblFLEX/+;Cre embryos, none was distinguishable from any other in terms of
the observed incidence of heart defects, but all were significantly different from NipblFLEX/+
(Fig 6D).
Key Determinants of ASD Risk Most Likely Lie Elsewhere in the Embryo
The above results indicate that Nipbl deficiency in either of two non-overlapping sets of cells—
the “cTnt lineage”, by which we mean descendants of cTnt-Cre expressing cells, and the “Sox17
lineage”, by which we mean descendants of Sox17-Cre expressing cells)—will cause heart
defects, while rescue of Nipbl deficiency in either of the same two populations rescues those
defects. With respect to the creation of heart defects, the first result implies that Nipbl defi-
ciency in either lineage is sufficient, while the second result implies that Nipbl deficiency in nei-
ther lineage is sufficient—which certainly seems paradoxical.
The problem is highlighted in tabular form in Table 1. NipblFlox/+;Cre experiments (“condi-
tional haploinsufficiency,” Fig 5) and NipblFLEX/+;Cre experiments (“conditional rescue,” Fig 6)
both generate embryos in which cardiomyocytes are Nipbl-deficient, and endoderm, endocar-
dium, and vascular endothelium are not; or endoderm, endocardium, and vascular endothe-
lium are deficient and cardiomyocytes are not. Yet opposite results, with respect to heart
defects, are obtained for the same genotypes in the two types of experiments. The key to resolv-
ing this apparent paradox is to remember the additional variable that distinguishes the two
classes of experiments: the rest of the embryo. In conditional haploinsufficiency experiments,
all lineages outside the one in which Cre acts are wildtype. In conditional rescue experiments,
all lineages outside the one in which Cre acts are Nipbl deficient.
For this difference between the genotypes of the rest of the embryo in the two experimental
approaches to explain the results, a critical determinant of ASD risk would have to lie in some
lineage other than those represented by cTnt and Sox17. Furthermore, in that lineage, risk
would have to be conferred by being Nipbl–wildtype, while protection would have to be con-
ferred by being Nipbl-deficient. That would explain why when the rest of the embryo is Nipbl–
wildtype, ASDs arise when either cardiac lineage is Nipbl-deficient, whereas when the rest of
the embryo is Nipbl-deficient, ASDs arise only when both are.
The possibility that an additional lineage protects against heart defects when Nipbl-deficient
led us to consider ways in which essentially non-cardiac developmental events might affect the
heart indirectly. One of the most penetrant phenotypes of Nipbl-deficiency is reduced body
size (by ~20% at birth; [22] and S3 Fig, Fig 7 below). Not surprisingly, the determinants of
body size lie outside the heart. As shown in Fig 7A–7E, in the NipblFlox/+ and NipblFLEX/+
crosses described above, body size is determined by Nipbl-status outside of the cTnt and Sox17
lineages (i.e., all carriers of the NipblFLEX allele are small, and all carriers of the NipblFlox allele
are normal in size). Yet it is also observed that heart size (measured as total ventricular volume)
correlates strongly with body size (Fig 7F–7I). Thus, lineages outside the heart and endoderm
Data: Sample Numbers) had an incidence of heart defects ranging from 0%–5% (A–D). Nipbl deficiency in
theWnt1 domain (neural crest) did not give rise to heart defects (E). CHDs occurred primarily in the form of
ASDs of the ostium secundum type (yellow arrowheads); VSDs observed in A and D are of the
perimembranous type. p-Values are from Chi-square analyses and are indicated for each corresponding
cross. Scale bar = 500 μm. lv, left ventricle; rv, right ventricle.
doi:10.1371/journal.pbio.2000197.g005
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Fig 6. Restoration ofNipbl expression in different heart lineages rescues heart defects.MRI analysis of
E17.5 hearts show that NipblFLEX/+mice exhibit ASDs at a frequency of ~30% (yellow arrowheads in A–C,
and D). The incidence of heart defects was significantly reduced in mice in which Nipbl was restored in all
tissues (NipblFLEX/+;Nanog-Cre), specifically in the cTnt domain (NipblFLEX/+;cTnt-Cre), or specifically in the
Sox17 domain (NipblFLEX/+;Sox17-2A-iCre) (D, asterisks: Chi-square, p < 0.05). Chi-square analysis on the
incidence of heart defects between the three rescued lines indicated no significant difference from one
another (Chi-square, p > 0.71). Progeny are on various backgrounds depending on parental backgrounds:
NipblFLEX/+ (mixed), wildtype (CD-1), cTnt-Cre (CD-1), Nanog-Cre (C57Bl6/J), and Sox17-2A-iCre (C57Bl6/
J); the incidence of heart defects inNipblFLEX/+ embryos from each of these crosses did not differ significantly
(p > 0.89 by Chi-square analysis; S1 Data). Size bar = 500 μm. lv, left ventricle; rv, right ventricle
doi:10.1371/journal.pbio.2000197.g006
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apparently determine the size of the embryonic heart, just as heart and body size are known to
scale together in adults [67]. Below (see Discussion), we raise the possibility that the results in
Table 1 might be explained by an influence of heart size on ASD risk, with large hearts being at
greater risk for defects than small ones.
Understanding the Incomplete Penetrance of Heart Defects
One of the puzzling aspects of the above experiments is that the incidence of ASDs always
seems to be either very low (5%) or about 30%, regardless of genotype. Particularly surprising
is the lack of increase in incidence when the entire embryo is Nipbl-deficient, as opposed to a
single lineage (e.g., Fig 5A–5C). Remarkably, a similar 30% incidence of heart defects is also
seen clinically in CdLS [14,15].
We wondered whether this 30% penetrance “ceiling” is a peculiarity of the specific gene
expression disturbances caused by Nipbl deficiency, or whether it reflects something about the
overall state of hearts at the time that Nipbl-sensitive defects emerge. For example, is it simply
that, at that stage, 30% of hearts are more labile to disturbances overall (e.g., due to embryo-to-
embryo variations in the intrauterine environment)?
To explore this idea, we decided to make mice doubly-heterozygous for Nipbl and Nkx2-5.
As discussed previously, Nkx2-5 is a key, early cardiac transcription factor. Moreover, Nkx2-5
gene dosage is clearly important in heart development, because haploinsufficiency for NKX2-5
gives rise to congenital heart disease in man [68,69]. As shown above (Fig 1F), early expression
of Nkx2-5 is reduced in Nipbl+/- embryos, so it is reasonable to suspect that at least some of the
cardiac phenotype of Nipbl+/- embryos arises from a deficiency in Nkx2-5. Combining Nipbl
and Nkx2-5 heterozygous mutations should then provide us with an opportunity to observe
the effects of lowering Nkx2-5 levels even further.
For these experiments, we used a knock-in Nkx2-5Cre allele as a null allele [55,70]. We con-
firmed that Nkx2-5Cre/+ hearts do in fact express Nkx2-5 at half the wildtype level using
qRT-PCR (S5 Fig), and hereafter refer to them as Nkx2-5+/-mice (it is the null state of this allele
that also made it unsuitable for use in the conditional experiments in Figs 5 and 6). We crossed
Nkx2-5+/- mice with our original Nipbl+/- mouse line, in which Nipbl is not flanked by LoxP
sites [22] (so the Cre produced by the Nkx2-5 transgenic mouse would be irrelevant), and eval-
uated hearts at E17.5.
As shown in Fig 8, even though Nkx2-5+/- mice only rarely display heart defects on their
own, Nipbl+/-; Nkx2-5+/- mice exhibit a much higher incidence of heart defects than Nipbl+/-
hearts (83% versus 30%), and a spectrum of defects that is both more varied in type and more
severe (Fig 8A and 8B). VSDs as well as ASDs were seen in Nipbl+/-; Nkx2-5+/- hearts, in several
Table 1. The incidence of atrial septal defects (ASD) as a function ofNipbl genotype in the heart.
Conditional haploinsufﬁciency experiments (Flox/+ x Cre)
Nipbl genotype in cardiomyocyte (cTnt) lineage Nipbl genotype in Sox17 lineage Frequent ASDs?
+/+ +/+ no
+/- +/+ yes
+/+ +/- yes
Conditional rescue experiments (FLEX/+ x Cre)
Nipbl genotype in cardiomyocyte (cTnt) lineage Nipbl genotype in Sox17 lineage Frequent ASDs?
+/+ +/+ no
+/- +/+ no
+/+ +/- no
doi:10.1371/journal.pbio.2000197.t001
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cases in combination; and two cases of persistent truncus arteriosus (PTA) were also observed
(Fig 8A–8C). Also apparent was a change in the angle of a subset of these hearts (Fig 8D), sug-
gestive of malrotation during development. Otherwise, Nipbl+/-;Nkx2-5+/- hearts are similar in
size (Fig 8E) and histology to Nipbl+/- hearts.
These results indicate that haploinsufficiency for Nkx2-5 can markedly enhance both the
incidence and severity of defects caused by Nipbl-deficiency, well above the 30% seen in
Fig 7. Relationships betweenNipbl genotype, embryo size, heart size, and ASDs. A. Table summarizing genotypes, heart size, body size
and incidence of ASDs in different crosses. B. RescuedNipblFLEX/+;cTnt-Cre embryos (n = 14) resembled theirNipblFLEX/+ littermates (n = 22) in
body size and were smaller than control littermates (cTnt-Cre n = 18, wildtype n = 31). C. Similar results were observed in rescuedNipblFLEX/+;
Sox17-2A-iCre embryos (n = 22; Sox17-2A-iCre n = 16; NipblFLEX/+ n = 18; wildtype n = 25). D. NipblFlox/+;cTnt-Cre (n = 15) were similar in overall
body size to littermate controls (NipblFlox/+ n = 14, cTnt-Cre n = 30, wildtype n = 21). E. Similar results were observed in NipblFlox/+;Sox17-2A-iCre
(n = 13) when compared to littermate controls (Sox17-2A-iCre, n = 20; NipblFlox/+ n = 10; wildtype n = 19). Note that individual weights for each
cross in B–E were normalized to the mean weight of cTnt-Cre controls (B, D), or Sox17-2A-iCre controls (C, E); black bars indicate normalized
mean weight for each genotype. F. Ventricular volume analyses (graphed as box plots) show that the overall heart size of rescuedNipblFLEX/+;
cTnt-Cre embryos (n = 7) were similar in size to NipblFLEX/+ heart size (n = 9) (Mann-Whitney U, p > 0.05). Control hearts (cTnt-Cre, n = 6) were
significantly larger than the hearts of theirNipblFLEX/+ andNipblFLEX/+;cTnt-Cre littermates (asterisks: Mann-Whitney U, p < 0.05). G. Rescued
NipblFLEX/+;Sox17-2A-iCre embryo hearts (n = 5) were also similar in size to NipblFLEX/+ littermate heart size (n = 6) (Mann-Whitney U, p > 0.05)
and significantly smaller than control hearts (Sox17-2A-iCre, n = 5) (asterisk: Mann-Whitney U, p < 0.05). H. Ventricular volume analysis show
that the ventricle size ofNipblFlox/+;cTnt-Cre embryos (n = 9), which display a high frequency of heart defects, were similar in size to control hearts
(cTnt-Cre, n = 9) (Mann-Whitney U, p > 0.05). I. NipblFlox/+;Sox17-2A-iCremutant hearts (n = 5), which also display a high frequency of heart
defects, were also similar in size to control hearts (Sox17-2A-iCre, n = 5) (Mann-Whitney U, p > 0.05).
doi:10.1371/journal.pbio.2000197.g007
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experiments in which lineages that display Nipbl-deficiency were individually manipulated.
Overall, the results imply that such heart defects are inherently sensitive to quantitative modu-
lation in the majority of embryos. Thus, the lack of significant phenotypic difference among
hearts in conditional Nipbl haploinsufficiency experiments in Fig 5A–5D, requires an alterna-
tive explanation (see Discussion).
Fig 8. Haploinsufficiency forNkx2-5 increases the incidence and severity of heart defects inNipbl-deficient
embryos. A. Nipbl+/-;Nkx2-5+/-mice displayed ASDs (yellow arrowhead), VSDs (green arrowhead), and/or PTAs (black
asterisk). B. Histogram showing increases in frequency and types of heart defects inNipbl+/-;Nkx2-5+/- hearts compared
to littermates of various genotypes; number of hearts observed with each type of defect is indicated. Data show that the
overall incidence of defects inNipbl+/-;Nkx2-5+/- hearts (83%) is significantly greater than in eitherNipbl+/- (30%,
p = 0.011 by Chi square) or Nkx2.5+/- (13%, p = 0.001 by Chi-square) hearts. C. Gross overview of the great vessels
highlighting PTA in Nipbl+/-;Nkx2-5+/-mice. D. Heart position and morphology in a subset of Nipbl+/-;Nkx2-5+/-mice was
drastically different than in littermates. Arrows indicate the position of the trachea (Tr), dotted lines originate at the
pulmonary artery and ends at the apex of the heart; note drastic change in the angle of dotted line in Nipbl+/-;Nkx2-5+/-
heart. E. Ventricular volumes for hearts of each genotype; horizontal bars indicate means. Ventricular volumes of Nipbl+/-;
Nkx2-5+/- hearts (n = 6) were similar in size to Nipbl+/- hearts (n = 5) (Mann-Whitney U, p > 0.05), whereas control hearts
(wildtype n = 5 andNkx2-5+/-, n = 5) were significantly larger than the hearts of their Nipbl+/- andNipbl+/-;Nkx2-5+/-
littermates (red asterisks: Mann-Whitney U, p < 0.05). ao, aorta; ASD, atrial septal defect; la, left atrium; lv, left ventricle;
pa, pulmonary artery; PTA, persistent truncus arteriosus; ra, right atrium; rv, right ventricle; Tr, trachea; VSD, ventricular
septal defect; Size bar = 500 μm.
doi:10.1371/journal.pbio.2000197.g008
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Discussion
The Nipbl+/- mouse—a model of Cornelia de Lange Syndrome (CdLS)—provides a unique
resource for studying how the combinatorial effects of genetic variation cause birth defects,
because the sole consequence of Nipbl haploinsufficiency appears to be small quantitative
adjustments to the levels of expression of hundreds to a thousand genes [21–23,25]. As
described above,Nipbl+/- mice display large ASDs—one of the most common CHDs in the gen-
eral population—at a frequency of about 30%, similar to the incidence of CHD in CdLS.
Not only do Nipbl+/- mice display defects of the atrial septum, which normally forms and
closes by E14.5 [30], they exhibit delayed closure of the ventricular septum, which normally
takes place a day earlier (Fig 1A), and reduction in the size of the right ventricle several days
before that (Fig 1C and 1D). Even earlier, at the cardiac crescent stage (E7.5), such mice show
decreased expression of Nkx2-5; and a day before that—at primitive streak stage (E6.5)—
reduced or delayed expression of the earliest-known marker of cardiogenic mesoderm,Mesp1.
These data suggest that the ASDs that arise in Nipbl-deficient embryos may have their origin in
events as early as gastrulation. This is in good agreement with findings in nipbl-deficient zebra-
fish, in which the origin of several heart defects could be traced to the initial migration of car-
diogenic mesoderm [23]. It also supports studies that suggest that CHDs frequently have early
developmental origins [51,68,71–73].
Early heart development involves interactions among all three germ layers of the embryo:
the mesoderm, which produces cardiomyocytes, endocardium, epicardium, and vascular endo-
thelium; the endoderm, which forms an essential substrate along which cardiomyocyte progen-
itors migrate and proliferate as they form the cardiac crescent; and the ectoderm, which is the
source of neural crest cells that contribute to the cardiac cushion and outflow tract [64]. To
sort out the relative contributions of different lineages to the production of ASDs in Nipbl-
deficient mice, we took advantage of recent improvements in gene-trap technology (Fig 2) to
selectively create, or rescue, Nipbl haploinsufficiency in cardiomyocytes, endoderm and endo-
cardium/endothelium, neural crest, or non-selectively throughout the entire embryo. The
results (Figs 5 and 6) implicated both the cTnt (cardiomyocyte) and Sox17 (endoderm and
endocardial/endothelial lineages), but not the neural crest. An absence of a role for neural crest
is consistent with its fairly late contribution to the heart (Fig 4F), relative to the early molecular
abnormalities that occur in the hearts of Nipbl-deficient mice (e.g., Fig 1F and 1G).
Surprisingly, we found that creating Nipbl haploinsufficiency in either the cTnt lineage, the
Sox17 lineage, or the entire embryo produced ASDs at the same frequency (Fig 5). Even more
surprisingly, we found that rescue of Nipbl haploinsufficiency in either of these two lineages
in an embryo that is otherwise globally Nipbl-deficient rescued those ASDs (Fig 6). These
results—in one case either lineage being sufficient to produce defects and in the other case nei-
ther lineage being sufficient to do so—imply that an additional determinant of CHD risk lies
outside of both lineages (and thus, most likely, outside both the heart and endoderm). That
determinant would have to be protective when the lineage responsible for it is Nipbl-deficient
(as all non-Cre-expressing lineages are Nipbl-deficient in conditional rescue experiments), but
it must be only partially protective in order to explain why globally Nipbl-deficient embryos do
get ASDs.
We speculate that this determinant may be heart size: Nipbl-deficient embryos are signifi-
cantly smaller than wildtype littermates, and so are their hearts. Moreover, heart size is clearly
determined by the Nipbl genotype of the rest of the body, not the genotype of the cells of the
cTnt and Sox17 lineages (Fig 7). The idea that having an abnormally small heart might lower
the risk of CHDmay seem counterintuitive, but it makes sense if we think of heart develop-
ment as a process in which a limited pool of progenitor cells must generate a large number of
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differentiated cells in a short period of time. Under such conditions, a shortfall in cell produc-
tion might be easier to tolerate if the heart that needs to be built is a smaller one.
This view fits with much of what we know about heart development. The heart is the earliest
organ system to become truly functional, and even short delays in cell production tend to be
lethal (for example, a 50% deficiency in developing cardiomyocytes at E9.5, due to cardiac-spe-
cific deletion of the growth-promoting gene Yap, leads to embryo death within one day [74]).
In mammals and birds, the need to rapidly remodel the initially simple linear heart tube into
an elaborate, four-chambered structure requires the addition of large numbers of cells, many of
which arrive by migration from the second heart field (SHF), a collection of cardiac progenitor
cells that lie outside the heart tube, and which have been adapted to undergo prolonged prolif-
eration [32,75,76]. Recent studies show the SHF provides most of the cells that drive the early
expansion of the heart, including cells that add to ventricles and atria and form both the atrial
septum and parts of the ventricular septum [32,34,76].
Interestingly, the SHF gives rise to almost the entire right ventricle [76], the same ventricle
that is disproportionately small in Nipbl+/- hearts (Fig 1). This result is consistent with a model
in which the output of the SHF is reduced in Nipbl–deficient embryos. An insufficiency of car-
diac progenitors would also be consistent with the reduced expression of Nkx2-5 andMesp1
expression that we observe in early Nipbl–deficient embryos. Furthermore, it would fit with
results in nipbl-deficient zebrafish, in which depletion of cardiac progenitors seems to be the
result of an insufficiency of endoderm along which such progenitors migrate [23]. Interest-
ingly, in that system, restoring the number of endoderm cells by overexpression of endoderm-
specific transcription factors rescues several heart defects.
One appealing feature of a model in which Nipbl deficiency drives progenitor cell numbers
to a point at which a large heart cannot always form properly, but a small heart can, is that this
model could potentially explain why the incidence of ASDs in conditional Nipbl-deficient mice
is always ~30%, regardless of whether Nipbl-deficiency occurs in the cTnt or Sox17 lineages
individually or throughout the entire embryo. It may simply be that, in globally Nipbl-deficient
animals, effects of reduced Nipbl in the cTnt lineage and the Sox17 lineage do interact addi-
tively, but we do not observe a stronger phenotype because of the protective effect of small
heart size in such mice, which exerts a phenotypic effect in the opposite direction. Future
experiments will be needed to verify this conjecture.
Overall, a consistent explanation for all of the conditional mutant phenotypes in the present
study is that Nipbl haploinsufficiency, in either the cardiac mesoderm or the endoderm upon
which it migrates (or both), leads to defective expansion of cardiac progenitors, with an ulti-
mate impact on cardiac morphogenesis that depends on the demands imposed by the rest of
the embryo on final heart size. Validating such an explanation will ultimately require measure-
ments of cell numbers and proliferation rates in very early embryos that are beyond the scope
of the present study. In addition, the present study did not evaluate possible contributions of
epicardium (which derives from neither the cTnt or Sox17 lineages) to Nipblmutant pheno-
types, although the timing at which epicardium appears during development suggests it could
not explain the early gene expression abnormalities described here (e.g., those in Fig 1F and
1G). Furthermore, since this study focused primarily on ASD, we cannot comment on whether
similar multilineage interactions are likely to play a role in other kinds of cardiac defects.
Nevertheless, the present work calls attention to the fact that the embryonic lineages respon-
sible for organogenesis can interact in ways both direct and indirect—global enforcement of
scaling relationships being an example of the latter. A consequence of indirect interaction is
that determinants of risk for developmental defects can easily turn up in unexpected places, as
they did here. This point may need to be kept in mind as efforts continue to be made to dis-
cover the genetic causes of human CHDs.
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Materials And Methods
Animals
Ethics statement. All animals were handled in accordance with approved procedures as
defined by the National Institutes of Health, and all animal work was approved by the Institu-
tional Animal Care and Use Committee of the University of California, Irvine. For collection of
mouse tissues, pregnant dams were humanely killed by CO2 anesthesia followed by cervical
dislocation. Noon on the day of vaginal plug appearance was designated embryonic day 0.5 (E
0.5). For young embryos (E7–E13.5), embryos were dissected in ice-cold PBS and tissue col-
lected for processing. For E17.5 mouse fetuses, fetuses were removed from the uterus, placed
on ice and immediately decapitated, then heart and other tissues removed for further study.
Genotyping. All mice and mouse embryos were genotyped by polymerase chain reaction
(PCR) using genomic DNA obtained from tail biopsies or tissues taken post-dissection. Primer
sequences and PCR conditions for all genotyping performed in these studies is detailed in
S2 Table.
Mouse lines. Nipbl+/- line: The Nipbl +/- mouse line (NipblGt(RRS564)Byg, MGI:4332250:
Nipbl+/-) was maintained on an outbred CD-1 (Charles River) background. Male Nipbl +/- mice
were naturally bred with females to obtain embryos used in these studies.
NipblFLEX/+ line: The NipblGt(EUCE313f02)Hmgu (MGI:4374347) embryonic stem (ES) cell line
was purchased from the European Conditional Mouse Mutagenesis Program (EUCOMM).
The FLEX genomic modification [33,53,54] to trap and inactivate the Nipbl gene, and success-
ful Cre-mediated recombination of the gene-trap allele to functional conformation, were con-
firmed in vitro by transiently transfecting pTurbo-Cre into NipblGt(EUCE313f02)Hmgu ES cells
([77,78]; S2 Fig). Verified ES cells were injected into C57Bl6/J (Jackson Laboratories) blasto-
cysts to generate chimeric male mice. Chimeras were mated with CD-1 females to obtain
NipblFLEX/+ progeny, which are phenotypically mutant (Fig 2B). NipblFLEX/+ mice were main-
tained on the CD-1 background.
NipblFlox/+ line: NipblFLEX/+ male mice were bred with Actin-FlpE females (Tg(ACTFLPe)
9205Dym, MGI:2448985, Jackson Laboratories)[79] to obtain progeny in which the NipblFLEX
allele was recombined to generate mice carrying the NipblFlox allele, in which LoxP and lox5171
recognition sites remained available for Cre-mediated recombination. Resulting Actin-FlpE/+;
NipblFlox/+ progeny were crossed with C57Bl6/J mice to segregate the recombined allele
(NipblFlox), and NipblFlox/+ mice were maintained thereafter on the C57Bl6/J background.
NipblFlox/+ and NipblFlox/Flox mice—now>10 generations on C57Bl6/J—are phenotypically
wildtype (Fig 2C).
NipblFlrt/+ line: NipblFLEX/+ male mice were bred with Nanog-Cremice to generate NipblFlrt/+
mice, in which the original NipblFLEX allele was recombined and Flp recognition sites (Frt and
F3) remained in active conformation. To isolate the NipblFlrt allele from the Nanog-Cre allele,
double heterozygous mice were crossed with CD-1 mice. NipblFlrt/+ mice are phenotypically
wildtype (Fig 2D). This line has not been maintained.
NipblFIN line: NipblFlox/+ mice were bred with Nanog-Cre to generate NipblFIN/+ mice.
NipblFIN/+ mice are Nipbl-deficient and phenotypically similar to Nipbl+/ and NipblFLEX/+mice
(Fig 2E). This line has not been maintained.
Recombinase and reporter mouse lines: The cTnt-Cre line (Tg(Tnnt2-cre)5Blh,
MGI:2679081, a gift from Dr. K. Jiao, (Univ. of Alabama, Birmingham, [56]) was maintained
on the CD-1 background. Nanog-Cremice [60] were a gift of Dr. A. Economides, Regeneron
Pharmaceuticals, and were maintained on C57BL/6J background. Sox17-2A-iCremice
(Sox17tm2.1(icre)Heli, MGI:4418897 [57]) and FoxA2-2A-iCremice (Foxa2tm1.1(icre)Hri, MGI:
5426440; [58]) were generated by Dr. Heiko Lickert (Helmholtz Institute, Munich) and were
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provided to us by Dr. Mario Cappecchi’s laboratory (University of Utah). Both lines were
maintained on C57BL/6J.Wnt1-Cremice (Tg(Wnt1-cre)11Rth, MGI:2386570) were a gift
from Dr. David Rowitch (U.C. San Francisco [59]), and were maintained on a CD-1 back-
ground. The Nkx2-5-Cre line (Nkx2-5tm1(cre)Rjs, MGI:2654594, [55]) was a gift from Dr. R.
Schwartz (Baylor College of Medicine). Nkx2-5-Cremice were obtained on a mixed back-
ground and maintained on C57BL/6J. The Actin-FlpE line (Tg(ACTFLPe)9205Dym,
MGI:2448985 [79]) was obtained from the Jackson Laboratory and maintained on C57BL/6J.
The reporter line used in these studies was Td-tomato-EGFP (Gt(ROSA)26Sor tm4(ACTB-tdTo-
mato,-EGFP)Luo, MGI:3716464 [61]). Homozygous Td-tomato-EGFPmice on C57BL/6J were pur-
chased from the Jackson Laboratory and maintained by interbreeding.
Generation of mouse embryos for testing tissue-specific depletion and rescue of Nipbl
expression. To generate embryos for Nipbl depletion experiments, NipblFlox/+ mice were nat-
urally mated with mice carrying any one of several Cre transgenes (Nanog-Cre, Sox17-2A-iCre,
FoxA2-2A-iCre,Wnt1-Cre, or cTnt-Cre). To generate embryos for Nipbl rescue experiments,
cryopreserved NipblFLEX/+ sperm was used for in vitro fertilization (IVF) of eggs from super-
ovulated females of indicated mouse lines heterozygous for Cre-expressing transgenes. Sperm
cryopreservation and IVF procedures were carried out by the UCI Transgenic Mouse Facility
using published procedures [80]. Because Cre-driver mice were not available on uniform
genetic backgrounds, potential genetic background effects in these experiments were mini-
mized by making comparisons within litters, or within groups of litters in which the distribu-
tion of genotypes across the litters was as uniform as possible.
Histochemistry, In Situ Hybridization, and Microscopy
Whole mount X-gal staining on E7.75–13.5 mouse embryos for detecting β-galactosidase activ-
ity was performed as described [81]. Histological evaluations were performed on tissue fixed in
4% paraformaldehyde (PFA) in phosphate buffer or neutral buffered formalin (VWR 16004–
126). Hematoxylin and Eosin Y (H&E) staining was performed on 20 μm cryosections (for
E13.5 hearts) or 7 μm paraffin sections (for E17.5 hearts) using standard techniques. E17.5
hearts were positioned at a canonical angle for analysis in histological sections and MRI stud-
ies: atria superior to ventricles, with the apex of the heart inferior and the left atrium and ven-
tricle to the right; sections were assessed from most ventral to most dorsal.
Whole mount ISH on E7.5–10.5 embryos was performed as described [82], except that for
E7.5 embryos, incubation time in proteinase K was reduced to 5 min. RNA probes for ISH
were generated as follows: 400 bp of Nkx2.5 transcript (997–1,396 bp of
ENSMUST00000015723); 353 bp of mouse Hand1 transcript (669––1,021 bp of
ENSMUST00000036917); and 901 bp of mouseMesp1 transcript (62–962 bp of
ENSMUST00000030544).
Whole mount ISH, X-gal, and fluorescent images, as well as all images of paraffin-sectioned
hearts, were obtained using a Discovery V8 stereomicroscope equipped with Axiovision soft-
ware (Zeiss). Confocal microscopy was performed on 30 μm sections of E15.5 hearts. Images
were taken every 5 μm using a 20x 0.75NA Olympus objective on an Olympus Fluoview
FV1000 microscope, and processed and stitched using Python and ImageJ Software as
described [83].
Magnetic Resonance Imaging (MRI)
Torsos from E17.5 embryos containing intact cardiopulmonary organs (heart and lungs) were
fixed in neutral buffered formalin for a minimum of 1 wk at 4°C. Intact torsos, or torsos with
ribs removed, were rinsed with phosphate buffered saline (PBS; 2 x 5 min.) and soaked in 2.5
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mMGadoteridol (Gd-HP-DO3A, a.k.a. ProHance, Braccoo Diagnostics Inc., Princeton, NJ) in
PBS for 12 h at 4°C. After soaking, samples were embedded in 2% low melting point (LMP)
agarose (Sea Plaque GTG Agarose, FMC Bioproducts) and stacked in a 20 mm diameter glass
tube. The chamber was then filled with perfluoro-polyether Galden-D (Inland Vacuum Indus-
tries, Churchville, New York) to limit tissue dehydration as well as susceptibility effects at the
surface of the specimen. Imaging was performed in a vertical bore 11.7T (500 MHz) Bruker
AVANCE imaging spectrometer with a microimaging gradient insert and 20 mm birdcage RF
coil. Images were acquired with a 3D RARE protocol (TR/TEeffective, 250 ms/16 ms) with a
RARE factor of 4 [84], voxel size of 503 μm3 with typical image matrix: 512x320x320 and field
of view (FOV): 25.6x16x16 mm3, and number of acquisitions = 10–18. The FOV and matrix
sizes were modified to accommodate differing numbers of samples and sample sizes. Scanning
was performed at 15°C to minimize noise.
Each heart from a scan was isolated as a file of 803 pixel3 using ImageJ (v. 1.45s). Heart
scans were evaluated for the presence or absence of ASD, VSD and/or PTA using the volume
viewer plug-in of ImageJ. Hearts were scored positive for ASD when: 1) a minimum of two
consecutive sections (100 microns) lacked atrial septum; 2) gap in atrial septum tissue was
greater than 3 pixels (150 microns); and 3) growth of both atrial septum walls (septum primum
and septum secundum) were stunted (observed as flat) at both the superior and inferior ends
of the developing atrial septum at the region of the atrio-ventricular valves. Hearts were scored
positive for VSD when ventricular septum was not continuous in one or more sections of the
MRI scan. Hearts were scored positive for PTA when the aorta and pulmonary artery were
observed as fused. Ventricular volumes were calculated from MRI data using the outline func-
tion of ImageJ: The outlined ventricle area was calculated for each section and multiplied by
section thickness (section thickness = 1 pixel or 50 μm); total ventricular volume for each heart
was calculated as the sum of these volumes. Heart defects detected by MRI were confirmed by
paraffin sectioning and histological staining. Chi-square test was used to calculate p-values for
the frequency of heart defects (ASD, VSD, and/or PTA) at E17.5 for all crosses. Mann-Whitney
U test was used to calculate p-values for measurements of the great vessels, ventricle wall thick-
ness, and ventricular volume at E17.5.
Optical Projection Tomography
E10.5 embryos were fixed in 4% PFA, washed thoroughly in PBS and embedded in LMP aga-
rose. Agarose blocks were affixed to metal mounts with cyanoacrylate Krazy Glue, trimmed,
dehydrated through three changes of methanol for 8–12 h, and then immersed in 2:1 benzyl
benzoate:benzyl alcohol mixture until optically clear (minimum 6 h). Specimens were scanned
using an optical projection tomography scanner (OPT 3001M; Bioptonics, United Kingdom),
under ultraviolet light using a GFP1 filter (exciter 425 nm/40 nm, emitter LP475 nm). Tomo-
graphic reconstruction was carried out using NRecon v. 1.6.1 (Skyscan, Belgium) to generate a
series of bitmap images. Three-dimensional reconstructions were rendered from stacked bit-
maps using ImageJ v. 1.41o (http://resb.info.nih.gov/ij) and Amira v. 5.2.2 (Visage Imaging,
USA).
Quantitative RT-PCR
RNA extraction was performed using an Aurum Total RNA kit (BioRad, USA) according to
the manufacturer’s instructions. RNA was reverse-transcribed into cDNA using oligo dT and
random hexamers with Superscript II reverse transcriptase (Invitrogen). Quantitative real-time
PCR amplifications were performed in an iQ5 iCycler real time PCR detection system (Bio-
Rad) using the iQ SYBR Green supermix (Bio-Rad). qRT-PCR was performed with primer sets
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given in S1 Table, using the following cycles: an initial cycle at 95°C for 3 min, followed by 40
cycles of 95°C for 10 s each, 59°C for 30 s, and 72°C for 30 s, followed by melt- curve analysis
from 61–95°C in 0.5°C increments. mRNA expression was normalized to expression of B-
2-microgoblulin (B2m) or glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and the rela-
tive expression of target genes was obtained by the 2-ddCt method [85]. A range of 3–14 biologi-
cal replicates (individual hearts between the ages of E10-13.5, brain or kidney at E17.5) were
assessed in technical duplicates or triplicates for each gene. Statistical significance was deter-
mined using Student’s t test (with Bonferroni correction where indicated).
Supporting Information
S1 Data. Sample numbers and all quantitative observations underlying the data summa-
rized in all Figures and Supporting Information Figures.
(XLSX)
S1 Table. Primer Sequences. The following primer sequences were used in Q-RT-PCR experi-
ments to detect mRNA expression levels of 29 cardiac developmental genes, plus Nipbl and
beta-2 microglobulin.
(XLSX)
S2 Table. Summary of transgenic mouse lines and PCR primers and conditions used for
genotyping.
(DOCX)
S1 Fig. Heart development genes showing no significant change in expression in Nipbl+/-
heart versus wildtype controls.Q-RT-PCR was performed as described in Materials and
Methods, and S1 Table. Values for each tested gene were normalized to expression value of
B-2-microgoblulin (B2M) in the same PCR run, and relative expression of tested genes was
obtained by the 2-ddCt method as described in Materials and Methods. 3–14 biological repli-
cates (individual hearts) were assayed in duplicate for each gene (see S1 Data). Data are
expressed as mean (± SEM); statistical significance was determined using Student’s t-test with
Bonferroni correction. No gene tested showed a significant difference in Nipbl+/- hearts versus
wildtype controls, except Nipbl, which was tested at E10.5 (52%, P<0.001).
(TIF)
S2 Fig. Conditional-invertible gene modifications of the Nipbl FLEX allelic series. A. Sche-
matic of EUCE313f02 (NipblFLEX) allele from which the Nipbl FLEX/+ mouse line and subse-
quent NipblFlox/+, NipblFlrt/+, and NipblFIN/+ mouse lines are derived using Cre and Flp DNA-
recombinases). Top: The SA-βgeo-pA (rsFlp-Rosa-bgeo) cassette in the NipblFLEX allele traps
Nipbl expression after Exon1, and instead expresses the β-geo reporter gene resulting in a null
allele. Middle: Flp recombinase (right path) inverts the SA-βgeo-pA cassette at frt and F3 sites,
simultaneously excising the heterotypic recognition targets, and locking the cassette against
reinversion, resulting in the NipblFlox allele. The same principle is adaptable to Cre recombi-
nase, using the LoxP and lox5171 sites, resulting in the NipblFlrt allele (left path). Either (Flp or
Cre mediated) inversion activates normal splicing between the endogenous splice sites (Exon 1
to Exon 2), skipping the inverted SA-βgeo-pA cassette, thereby repairing the mutation and
resulting in a phenotypically-wildtype allele. Bottom: Subsequent Cre (right path) or Flp (left
path) recombinase-mediated inversion repositions the SA-βgeo-pA cassette, activating the
gene-trap again, and re-introducing the mutation, resulting in the phenotypically null NipblFIN
allele. Each allele can be distinguished by genomic PCR, in which primers are designed within
the rsFlp-Rosa-βgeo cassette (across the β-geo reporter and the arm of cassette outside of the
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recognition sites; white: B050, gray: B048, and black: B045 arrows). Each genomic conforma-
tion yields a PCR amplicon of a different size (NipblFLEX: 652 bp, NipblFlox: 782bp, NipblFlrt:
735 bp, and NipblFIN: 518 bp, also see S2 Table). Frt (purple triangles) and F3 (green triangles)
are heterotypic target sequences for FLP recombinase; loxP (orange triangles) and lox5171 (yel-
low triangles) are heterotypic target sequences for Cre-recombinase; SA, splice acceptor; β-geo,
β-galactosidase/neomycin phosphotransferase fusion gene; pA, bovine growth hormone polya-
denylation sequence. B. Schematic showing the location of PCR primers to detect the wildtype
Nipbl allele (black and blue arrowheads show Nipbl forward Nipbl reverse primers, respectively;
492 bp amplicon) and any of the NipblGt(EUCE313f02)Hmgu derivatives (NipblGt) containing the
rsFlp-Rosa-βgeo cassette (red arrowhead shows 313f02 forward primer, blue arrowhead, Nipbl
reverse primer; 302 bp amplicon). C. To ensure that the rsFlp-Rosa-βgeo cassette can undergo
recombinase-mediated inversion, EUC313f02 NipblFLEX/+ ES cells were electroporated with
pTurbo-Cre to convert the NipblFLEX allele to the NipblFlrt conformation in vitro. After the
pTurbo-Cre plasmid was electroporated into ES cells, clonal colonies were isolated and
screened by PCR genotyping, X-gal staining, and sensitivity to G418 to identify NipblFlrt/+
clones. For X-gal staining, ES cells were fixed for 10 minutes in 2 mMMgCl2, 0.5% glutaralde-
hyde in 1X PBS, followed by a 30 minute wash (2 mMMgCl2 in 1xPBS), and permeabilization
(0.2 mMMgCl2, 0.1% Triton X-100, 0.01% deoxycholate in 1xPBS), all at room temperature.
X-gal staining (5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 2 mMMgCl2, 0.1% Triton X-100, 0.01%
deoxycholate, 1 mg/mL X-gal) was performed at 37°C until blue precipitate was detected. For
G418 selection, ES cells were treated with 0.1mg/ml of G418 (Gibco) in E14TG2A medium
(protocol available at https://www.eummcr.org/protocols/tissue-culture_e14tg2a.pdf) contain-
ing 1000 U/ml leukemia inhibitory factor (LIF: ESGROMillipore, Massachusetts, USA).
Medium was changed daily for 8 days. Only NipblFLEX/+ ES cells were positive for X-gal stain-
ing and resistant to G418 treatment. In contrast, E14Tg2A (wildtype) and Nipbl Flrt/+ ES cells
were not stained by X-gal and cells were killed by G418 exposure. Scale bar = 500 μm. D.
Q-RT-PCR results showing reduced Nipbl expression in NipblFLEX/+ ES cell clones, and normal
Nipbl expression levels in NipblFLEX/+ ES cell clones transfected with p-Turbo Cre (i.e.
NipblFlrt/+ clones). NipblmRNA expression was calculated as the ratio of the Ct value for Nipbl
normalized to the Ct value for Gapdh in the same sample (dCt). Data are shown as 2-dCt (x
10−2) for individual ES cell clones; error bars in graph represent the range of 2-dCt values of
technical duplicates from each individual ES cell clone. Nipbl Q-RT-PCR primers and condi-
tions are described in Materials and Methods, S1 Table and S1 Fig. E. Representative gel show-
ing PCR genotyping for NipblGt and wildtype alleles. PCR results show Nipbl alleles present in
NipblFlox/+ tissue (WT: 492 bp and NipblGt: 302 bp) and wildtype littermates (WT: 492 bp
only), using primers shown in B and detailed in S2 Table. F. Representative gel showing PCR
results for tissues from mice representing the complete NipblFLEX allelic series (NipblFLEX/+: 652
bp, NipblFlox/+: 782 bp, NipblFlrt/+: 735 bp, and NipblFIN/+: 518 bp) using the 3-primer PCR
described in A and S2 Table.
(TIF)
S3 Fig. Growth retardation and poor survival of NipblFLEX/+ mice is rescued in NipblFlox/+
and NipblFlrt/+mice. A. Growth curves of NipblFLEX/+ mice compared to wildtype littermates
from post-natal day (P) 1 to P21, from 17 litters. Data are pooled by genotype (wildtype,
NipblFLEX/+ or not genotyped due to early demise) and survival status (survived to weaning ver-
sus died before weaning), from birth to weaning at P21. For clarity, only upper error bars (stan-
dard deviation, SD) are shown for wildtype and NipblFLEX/+ daily weight averages. Data show
that wildtype mice gain weight steadily for the first 21 days of life (black circles), whereas
NipblFLEX/+ survivors (red open boxes) and non-survivors (blue filled boxes) grow at impaired
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rates. The weights of NipblFLEX/+ mice overlapped within the first few days of life regardless of
whether they survived to weaning or not. Growth of un-genotyped non-survivors (green Xs)
was similar to NipblFLEX/+ non-survivors (blue filled boxes) within the first 12 days of life, sug-
gesting that pups that failed to survive were likely NipblFLEX/+. Some pups that were logged as
having been born could not be genotyped because tissue could not be recovered. B. Growth
curves of NipblFlox/+mice compared to wildtype littermates from P1 to P21, from 5 litters. Data
are pooled by genotype. Data show overlapping growth and similar sizes of wildtype and
NipblFlox/+mice. For purposes of clarity, only upper error bars for NipblFlox/+ mice (SD, blue)
and lower error bars for wildtype (SD, black) are shown. C. Growth curves for NipblFlrt/+ mice
compared to wildtype littermates from P1 to P21, from 4 litters. Data show overlapping growth
and similar weights of wildtype and NipblFlrt/+ mice. For purposes of clarity, only upper error
bars for NipblFlrt/+ mice (SD, green) and lower error bars for wildtype (SD, black) are shown.
(TIF)
S4 Fig. NipblFLEX/+ hearts do not display pulmonary stenosis, aortic stenosis, or ventricular
hypertrophy. To assess stenosis, diameters of the aorta and pulmonary artery were measured
from images using Axiovision software (Zeiss). 90% of pulmonary stenoses are isolated at the
valvular region, so diameters were measured just distal to the semilunar valves (supravalvular).
To confirm that any stenoses observed did not involve the pulmonary trunk/aorta, serial sec-
tions were followed by the observer to the bifurcation. To assess hypertrophic cardiomyopathy,
ventricular wall thickness was measured and the ratio of the right to left wall thickness was cal-
culated for each sample, and different genotypes were compared. Diameter of the ventricular
wall (left and right myocardium, excluding trabeculae) was measured in images of H&E stained
paraffin sections in the region that was midway through the atrioventricular valve (ventral-dor-
sal) and midway through the ventricular septum (superior to inferior). A. The supravalvular
diameter of the great arteries of paraffin sectioned wildtype and NipblFLEX/+ hearts were mea-
sured as indicated by black bar. B. Both the pulmonary artery diameter and the aorta diameter
(C) were significantly smaller in NipblFLEX/+ hearts (N = 11) compared to wildtype littermates
(N = 9) (Mann-Whitney U, P<0.05). D. The thickness of the ventricular walls (excluding trabi-
culae) were measured as indicated by black bar. Ventricular wall thickness was significantly
reduced in NipblFLEX/+ hearts (N = 11) compared to wildtypes (N = 9) on both the right (E)
and left (F) walls (Mann-Whitney U, P<0.025). G. A ratio of the right to left ventricle wall
thickness revealed no significant difference between wildtypes and NipblFLEX/+ mice (Mann-
Whitney U P>0.05). Differences observed in C, D, E, and F likely due to the overall smaller
body and heart size observed in NipblFLEX/+ embryos (see results and Fig 7). LV, left ventricle;
PA, pulmonary artery; RV, right ventricle.
(TIF)
S5 Fig. Nkx2-5Cre/+ hearts have half the normal level of Nkx2-5 expression. Q-RT-PCR was
performed on E10.5 Nkx2-5+/+ (N = 7) and Nkx2-5Cre/+ (N = 5) hearts. Nkx2-5Cre/+ hearts had
approximately half the Nkx2-5 expression of Nkx2-5+/+ littermates. Nkx2-5 mRNA expression
was normalized to expression of B2m, and the relative expression of Nkx2-5 was obtained by
the 2-ddCt method; data are expressed as mean ± SEM. PCR primers and conditions are
described in Materials and Methods, and S1 Table. Asterisk: Student’s t-test, P = 0.001.
(TIF)
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